Immorta Bio's SenoVax™ Reduces Growth and Stops Metastasis of Aggressive Breast Cancer Using its First-In-Class Immune Stimulatory Therapy

Seaking Alpha

Seeking Alpha / Seaking Alpha 1 Views

SenoVax Successfully "Teaches" Immune System to Remove Protective Shield Around Tumors in Animal Models MIAMI BEACH, Fla., Oct. 29, 2024 /PRNewswire/ -- Immorta Bio Inc., a scientific longevity company focused on "Treating Diseases of Aging and Treating Aging as Disease™," announced today...

Comments